U.S. markets close in 25 minutes

Agile Therapeutics, Inc. (AGRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6500+0.0400 (+1.53%)
As of 3:33PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 8/3/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
218.03M162.22M174.53M70.27M63.87M
Enterprise Value 3
139.71M127.91M156.37M59.94M52.59M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
2.413.555.473.052.64
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-6.57-17.19-26.15-13.65-15.26

Trading Information

Stock Price History

Beta (5Y Monthly) 1.47
52-Week Change 3146.23%
S&P500 52-Week Change 314.33%
52 Week High 34.7650
52 Week Low 30.3500
50-Day Moving Average 32.6581
200-Day Moving Average 32.6884

Share Statistics

Avg Vol (3 month) 31.99M
Avg Vol (10 day) 31.05M
Shares Outstanding 587.21M
Float 65.5M
% Held by Insiders 10.69%
% Held by Institutions 138.86%
Shares Short (Jul 14, 2020) 44.51M
Short Ratio (Jul 14, 2020) 42.14
Short % of Float (Jul 14, 2020) 46.38%
Short % of Shares Outstanding (Jul 14, 2020) 45.17%
Shares Short (prior month Jun 14, 2020) 42.93M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-20.15%
Return on Equity (ttm)-37.86%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.6M
Net Income Avi to Common (ttm)-21.82M
Diluted EPS (ttm)-0.3680
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)93.92M
Total Cash Per Share (mrq)1.08
Total Debt (mrq)15.6M
Total Debt/Equity (mrq)17.22
Current Ratio (mrq)33.69
Book Value Per Share (mrq)1.04

Cash Flow Statement

Operating Cash Flow (ttm)-18.61M
Levered Free Cash Flow (ttm)-10.86M